Biomarker Discovery for GLP-1 Response, End to End at ASHG
Join us in Montréal to discover how Ovation and DNAnexus accelerate translational research on a single platform
Wednesday, Oct 21st at 3:00pm
RSVP Now
Industry Education Workshop:
Wednesday, Oct 21st from 3:00 - 4:00pm
Room 513ABC at ASHG
End-to-End Biomarker Discovery on One Platform: Statistical Genetics and AutoML Applied to GLP-1 Response
Discover how combining real-world clinical data, multiomic assets and flexible computational tooling on a single platform can accelerate translational research- empowering teams across the discovery-to-clinic continuum to collaborate on complex therapeutic questions like GLP-1 response heterogeneity.
Speakers
Barry Wark
Co-Founder & Chief Strategy Officer
Ovation.io
Ovation.io
Todd Oakland, PhD
SVP, GM Biopharma Rx/Dx
DNAnexus
DNAnexus
RSVP for this Workshop
